23 March 2010

Amino Acid Catabolism: Carbon Skeletons



Amino Acid Catabolism: Carbon Skeletons
Copyright © 1999-2007 by Joyce J. Diwan.
All rights reserved.

Molecular Biochemistry II

Amino Acid Carbon Skeletons
Amino acids, when deaminated, yield a-keto acids that, directly or via additional reactions, feed into major metabolic pathways (e.g., Krebs Cycle).
Amino acids are grouped into 2 classes, based on whether or not their carbon skeletons can be converted to glucose:

o glucogenic
o ketogenic.

Carbon skeletons of glucogenic amino acids are degraded to:
o pyruvate, or
o a 4-C or 5-C intermediate of Krebs Cycle. These are precursors for gluconeogenesis.
Glucogenic amino acids are the major carbon source for gluconeogenesis when glucose levels are low.
They can also be catabolized for energy, or converted to glycogen or fatty acids for energy storage.

Carbon skeletons of ketogenic amino acids are degraded to:
o acetyl-CoA, or
o acetoacetate.

Acetyl CoA, & its precursor acetoacetate, cannot yield net production of oxaloacetate, the gluconeogenesis precursor.
For every 2-C acetyl residue entering Krebs Cycle, 2 C leave as CO2.
Carbon skeletons of ketogenic amino acids can be catabolized for energy in Krebs Cycle, or converted to ketone bodies or fatty acids.
They cannot be converted to glucose.
The 3-C a-keto acid pyruvate is produced from alanine, cysteine, glycine, serine, & threonine.
Alanine deamination via Transaminase directly yields pyruvate.
Serine is deaminated to pyruvate via Serine Dehydratase.
Glycine, which is also product of threonine catabolism, is converted to serine by a reaction involving tetrahydrofolate (to be discussed later).

The 4-C Krebs Cycle intermediate oxaloacetate is produced from aspartate & asparagine.
Aspartate transamination yields oxaloacetate.
Aspartate is also converted to fumarate in Urea Cycle. Fumarate is converted to oxaloacetate in Krebs cycle.
Asparagine loses the amino group from its R-group by hydrolysis catalyzed by Asparaginase.
This yields aspartate, which can be converted to oxaloacetate, e.g., by transamination.
The 4-C Krebs Cycle intermediate succinyl-CoA is produced from isoleucine, valine, & methionine.
Propionyl-CoA, an intermediate on these pathways, is also a product of b-oxidation of fatty acids with an odd number of C atoms.
The branched chain amino acids initially share in part a common pathway.
Branched Chain a-Keto Acid Dehydrogenase (BCKDH) is a multi-subunit complex homologous to Pyruvate Dehydrogenase complex.
Genetic deficiency of BCKDH is called Maple Syrup Urine Disease (MSUD).
High concentrations of branched chain keto acids in urine give it a characteristic odor.
Propionyl-CoA is carboxylated to methylmalonyl-CoA.
A racemase yields the L-isomer essential to the subsequent reaction.
Methylmalonyl-CoA Mutase catalyzes a molecular rearrangement: the branched C chain of methylmalonyl-CoA is converted to the linear C chain of succinyl-CoA.
The carboxyl that is in ester linkage to the thiol of coenzyme A is shifted to an adjacent carbon atom, with opposite shift of a hydrogen atom.

Recall that coenzyme A is a large molecule.
Coenzyme B12, a derivative of vitamin B12 (cobalamin), is the prosthetic group of Methylmalonyl-CoA Mutase.
A crystal structure of the enzyme-bound coenzyme B12.
Coenzyme B12 contains a heme-like corrin ring with a cobalt ion coordinated to 4 ring N atoms.
o methyl C atom of 5'-deoxyadenosine (not shown).
o an enzyme histidine N
When B12 is free in solution, a ring N of the dimethylbenzimidazole serves as axial ligand to the cobalt.
When B12 is enzyme-bound, a His side-chain N substitutes for the dimethylbenzimidazole.
Within the active site, the Co atom of coenzyme B12 has 2 axial ligands:
Homolytic cleavage of the deoxyadenosyl C-Co bond during catalysis yields a deoxyadenosyl carbon radical, as Co3+ becomes Co2+.
Reaction of this with methylmalonyl-CoA generates a radical substrate intermediate and 5'-deoxyadenosine.
Following rearrangement of the substrate, the product radical abstracts a H atom from the methyl group of 5'-deoxyadenosine.
This yields succinyl-CoA and the 5'-deoxyadenosyl radical, which reacts with coenzyme B12 to reestablish the deoxyadenosyl C-Co bond.

Methyl group transfers are also carried out by B12 (cobalamin).
Methyl-B12 (methylcobalamin), with a methyl axial ligand substituting for the deoxyadenosyl moiety of coenzyme B12, is an intermediate of such transfers.
E.g., B12 is a prosthetic group of the mammalian enzyme that catalyzes methylation of homocysteine to form methionine (to be discussed later).
o Vitamin B12 is synthesized only by bacteria.
Ruminants get B12 from bacteria in their digestive system.
Humans obtain B12 from meat or dairy products.
o Vitamin B12 bound to the protein gastric intrinsic factor is absorbed by cells in the upper part of the human small intestine via receptor-mediated endocytosis.
B12 synthesized by bacteria in the large intestine is unavailable.
Strict vegetarians eventually become deficient in B12 unless they consume it in pill form.
o Vitamin B12 is transported in the blood bound to the protein transcobalamin, which is recognized by a receptor that mediates uptake into body cells.

Explore via Chime
Methylmalonyl-CoA Mutase
with its prosthetic group,
Coenzyme B12.
Desulfo-CoA (without the
thiol) is at the active site.
The deoxyadenosyl moiety is lacking in the crystal.

The 5-C Krebs Cycle intermediate a-ketoglutarate is produced from arginine, glutamate, glutamine, histidine, & proline.
Glutamate deamination via Transaminase directly yields a-ketoglutarate.
Glutamate deamination by Glutamate Dehydrogenase also directly yields a-ketoglutarate.
Histidine is first converted to glutamate. The last step in this pathway involves the cofactor tetrahydrofolate.
Tetrahydrofolate (THF), which has a pteridine ring, is a reduced form of the B vitamin folate.
Within a cell, THF has an attached chain of several glutamate residues, linked to one another by isopeptide bonds involving the R-group carboxyl.
THF exists in various forms, with single-C units, of varying oxidation state, bonded at N5 or N10, or bridging between them.
In these diagrams N10 with R is r-aminobenzoic acid, linked to a chain of glutamate residues.
The cellular pool of THF includes various forms, produced and utilized in different reactions.
N5-formimino-THF is involved in the pathway for degradation of histidine.
Reactions using THF as donor of a single-C unit include synthesis of thymidylate, methionine, f-methionine-tRNA, etc.
In the pathway of histidine degradation, N-formiminoglutamate is converted to glutamate by transfer of the formimino group to THF, yielding N5-formimino-THF.
Because of the essential roles of THF as acceptor and donor of single carbon units, dietary deficiency of folate, genetic deficiencies in folate metabolism or transport, and the increased catabolism of folate seen in some disease states, result in various metabolic effects leading to increased risk of developmental defects, cardiovascular disease, and cancer.

Aromatic Amino Acids
Aromatic amino acids phenylalanine & tyrosine are catabolized to fumarate and acetoacetate.
Hydroxylation of phenylalanine to form tyrosine involves the reductant tetrahydrobiopterin. Biopterin, like folate, has a pteridine ring.
Dihydrobiopterin is reduced to tetrahydrobiopterin by electron transfer from NADH.
Thus NADH is secondarily the e- donor for conversion of phenylalanine to tyrosine.
Overall the reaction is considered a mixed function oxidation, because one O atom of O2 is reduced to water while the other is incorporated into the amino acid product.
O2, tetrahydrobiopterin, and the iron atom in the ferrous (Fe++) oxidation state participate in the hydroxylation.
O2 is thought to react initially with the tetrahydrobiopterin to form a peroxy intermediate.
Phenylalanine Hydroxylase includes a non-heme iron atom at its active site.
X-ray crystallography has shown the following are ligands to the iron atom:
His N, Glu O & water O.
(Fe shown in spacefill & ligands in ball & stick).
deamination via transaminase) accumulate in blood & urine.
Mental retardation results unless treatment begins immediately after birth. Treatment consists of limiting phenylalanine intake to levels barely adequate to support growth. Tyrosine, an essential nutrient for individuals with phenylketonuria, must be supplied in the diet.
Genetic deficiency of Phenylalanine Hydroxylase leads to the disease phenylketonuria.
Phenylalanine & phenylpyruvate (the product of phenylalanine
Tyrosine is a precursor for synthesis of melanins and of epinephrine and norepinephrine.
High [phenylalanine] inhibits Tyrosine Hydroxylase, on the pathway for synthesis of the pigment melanin from tyrosine. Individuals with phenylketonuria have light skin & hair color.
Methionine S-Adenosylmethionine by ATP-dependent reaction.
SAM is a methyl group donor in synthetic reactions.
The resulting S-adenosylhomocysteine is hydrolyzed to homocysteine.
Homocysteine may be catabolized via a complex pathway to cysteine & succinyl-CoA.
Or methionine may be regenerated from homocysteine by methyl transfer from N5-methyl-tetrahydrofolate, via a methyltransferase enzyme that uses B12 as prosthetic group.
The methyl group is transferred from THF to B12 to homocysteine.
Another pathway converts homocysteine to glutathione.
In various reactions, S-adenosylmethionine (SAM) is a donor of diverse chemical groups including methylene, amino, ribosyl and aminoalkyl groups, and a source of 5'-deoxyadenosyl radicals.
But SAM is best known as a methyl group donor.

Examples:
S-adenosylmethionine as methyl group donor
o methylation of bases in tRNA
o methylation of cytosine residues in DNA
o methylation of norepinephrine epinephrine
o conversion of the glycerophospholipid
phosphatidyl ethanolamine phosphatidylcholine via methyl transfer from SAM.
Enzymes involved in formation and utilization of S-adenosylmethionine are particularly active in liver.
Liver has important roles in synthetic pathways involving methylation reactions, & in regulation of blood methionine.
Methyl Group Donors

Methyl group donors in synthetic reactions include:

* methyl-B12
* S-adenosylmethionine (SAM)
* N5-methyl-tetrahydrofolate (N5-methyl-THF)
Lysine & Tryptophan

Amino Acid Catabolism: Carbon Skeletons.ppt

Read more...

Phenylketonuria (PKU)



Phenylketonuria (PKU)
(fen'-il-kee'-to-nu'-ria)
By:Ashley Ryan

What is PKU?

* An inherited metabolic disease in which mental retardation can be prevented by a specific diet
* 1 out of 50 people are carriers of defective gene; 1 in 10,000 births
* Rare condition where a baby is born lacking the ability to break down phenylalanine.
* Phenylalanine is an amino acid found in many foods. It is characterized by higher than normal levels of phenylalanine in the blood which can cause damage to the brain and mental retardation
* The brain suffers and is damaged due to a tremendous buildup of phenylalanine

*This then results in damage of the CNS & causes brain damage

Causes & Symptoms
* Since PKU is inherited it is passed down through families
* Which means both parents must pass on the defective gene to there offspring; known as an autosomal recessive trait
* Phenylalanine is involved in the body’s production of melanin which is the pigment for skin and hair color – children with PKU generally have lighter skin, hair and eyes
* Other symptoms include

Treatment
* PKU is in fact treatable with the correct strictly followed diet very low in phenylalanine
* If diet is not followed brain impairment can occur or error of metabolism can be associated with M.R in first year of life.
* Association with attention-deficit hyperactivity disorder (ADHD) most common problem in those who don’t follow a strict diet
* If diet is properly followed esp. in first few years of life where it is most crucial an outcome of better physical and mental health will follow
* Examples of foods low in phenylalanine: milk, eggs, fish oil, special formula called Lofenalac .
* Lofenalac provides essential amino acids and can be used throughout life. It not only provides amino acids but also vitamins and minerals.
* Can think of it as a super food for PKU patients

Testing for PKU
* It is IMPERTATIVE that phenylalanine restrictions on diet is introduced after birth to prevent the neurodevelopment effects of PKU
* How is PKU tested?
* Blood is routinely drawn from the infants for testing
* A “heel stick” is done and then collected on special blotter paper
* Routine testing includes phenylketonuria and blood type

Prevention
* Overall highly recommend to have strong relationship with physician
* An Enzyme Assay can determine if parents carry defective gene
* Chorionic villus Sampling - screen unborn baby for possibility of PKU
* It is very important that women with PKU closely follow a strict low-phenylalanine diet both before becoming pregnant and throughout the pregnancy, since build-up of this substance will damage the developing baby even if the child has not inherited the defective gene.

Age and Diet- controversy
* The age when a diet can or should be discontinued has been debatable over decades
* Generally- PKU centers advise a life-long diet  especially for female patients
* A study was done that looked at progress of children who ended their diet at an early age
* the main focus of the study was the effects on neurological/ intellectual performance
* The participants abilities were compared during treatment and after the diet was discontinued
* RESULTS- It was shown that children who maintained the diet had fewer deficits to those terminating the diet before the age of 10
* Overall the study said a diet should remain strict to at least the age of 10!
* Although this was said also recommended to maintain diet in adulthood
* can be modified but not completely eliminated

Issues in Adults with PKU
* Several studies said that discontinuation of diet effect
* New problems with PKU:
* Adults w/ PKU who remained on diet but weren't as strict w what they ate showed white matter abnormalities when given MRI indicating a reduction in myelin.
* *** These conditions disappeared after reintroducing the strict diet ***
* Neurological investigations in early treated adults w/ PKU who stopped the diet showed higher incidence of neurological signs including:

-tremors
-clumsy motor coordination
* Investigation on Psychological problems also
-severe behavior/ psychiatric problems are seen in profound retarded/untreated adults w/ PKU in their 30’s-40’s.
* Claims that reintroduction of restricted diet symptoms can sometimes be reversible
* Adults who discontinued the diet have had cases of
* - depression, anxiety, social withdrawal, phobias, low self-esteem, neurotic behavior
* In 2009 it was stated PKU patients should be encouraged to remain on a life long diet and also recommended to:

-take nutritional supplements
* Blood PhE levels should be monitored every 3 months
* Yearly clinical review
* PKU pregnant women recommendations include:
* Being under control of physician specialized in
* metabolic disease, gynecologist, and dietician
* Detailed ultrasound @ 20 weeks of gestation
* Seen every 3 to 4 weeks and blood PhE levels monitored at least 1 a week

Factors to consider when people discontinue restricted diets
* Difficulty maintaining diet for older children
* State support of formula costs is decreasing
* In 1978 85% of PKU programs received financial backing, within 6 years 66% of people received financial support
* Formula Cost can range from $5,000 to $7,000 a year. For a young adult and families can be a problem financially if not receiving any support
* Therefore, when people do stop the restricted diet its important to consider and assess financial, nutritional, social, psychological problems that people encounter trying to maintain the diet. And remember that in some cases people don’t discontinue the diet because they want to they may be unable to.

Reference Page
Phenylketonuria (PKU)

Read more...

Case Study: Phenylketonuria (PKU)



Case Study: Phenylketonuria (PKU)
By: Bobby Orr
Adam Edwards
Danielle Heinbaugh

Introduction: What is PKU?
* PKU (Phenylketonuria) is a disorder defined as the inability to metabolize the essential amino acid phenylalanine
* This can cause mental retardation, if untreated, although sufficient treatment can occur immediately after birth

Symptoms:
* The main symptom consists of mild to moderate mental retardation, but this is easily prevented through treatment
* However, other side effects include seizures, vomiting, a “mousy odor”, and behavioral self-mutilation
* In some cases, treatment can reduce or reverse the mental retartadtion

The Guthrie Test:
* determines the phenylalanine level in the blood
* should be done on the second or third day of life
* is a screening test done to identify elevated phenylalanine levels it is not diagnostic
* PKU babies’ phenylalanine level is usually 20-40 mg/dl in comparison with normal levels of 4-6 mg/dl.

How the Guthrie Test works:
* Blood on filter paper is placed on agar plates with a strain of bacillus subtilis that requires phenylalanine for growth.
* The presence of growth is indicated by a halo surrounding the filter paper.
* If positive, blood phenylalanine and tyrosine levels are determined, and if elevated, a confirmatory assay for phenylalanine hydroxylase is done.

PKU Inheritance:
* Inherited as autosomal recessive disorder.
* Variation to classical symptoms is result of compound heterogeneity.
* 65 allelic variants make compound heterogeneity more common then homogeneity for the same allele.

Treatment of PKU:
* Phenylketonuria is treatable with a low phenylalanine diet.
* phenylalanine levels should be kept below 15 mg per deciliter
* Nutra sweet is especially high in phenylalanines

Genetic Counseling:
* Tell the parents that the baby will be normal if they follow the prescribed dietary guidelines
* The child is normally out of danger of the disease after puberty
* Phenylalanine should be avoided
o Stay away from nutra sweet, meats, dairy products

Case Study: Phenylketonuria (PKU)

Read more...
All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP